Rosenberg IH. Sarcopenia: origins and clinical relevance. Clin Geriatr Med. 2011;27(3):337–9.
Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39(4):412–23.
Article PubMed PubMed Central Google Scholar
Sabel MS, Lee J, Cai S, Englesbe MJ, Holcombe S, Wang S. Sarcopenia as a prognostic factor among patients with stage III melanoma. Ann Surg Oncol. 2011;18(13):3579–85.
Strassmann D, Hensen B, Grunwald V, Stange K, Eggers H, Langer F, et al. Impact of sarcopenia in advanced and metastatic soft tissue sarcoma. Int J Clin Oncol. 2021;26(11):2151–60.
Article PubMed PubMed Central Google Scholar
Harimoto N, Shirabe K, Yamashita YI, Ikegami T, Yoshizumi T, Soejima Y, et al. Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma. Br J Surg. 2013;100(11):1523–30.
Article CAS PubMed Google Scholar
Shin SP, Koh DH. Clinical impact of sarcopenia on cholangiocarcinoma. Life (Basel). 2022;12(6):815.
CAS PubMed PubMed Central Google Scholar
van Vledder MG, Levolger S, Ayez N, Verhoef C, Tran TC, Ijzermans JN. Body composition and outcome in patients undergoing resection of colorectal liver metastases. Br J Surg. 2012;99(4):550–7.
Kanis JA. Diagnosis of osteoporosis and assessment of fracture risk. Lancet. 2002;359(9321):1929–36.
Raisz LG. Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Investig. 2005;115(12):3318–25.
Article CAS PubMed PubMed Central Google Scholar
Sharshar M, Kaido T, Shirai H, Okumura S, Yao S, Miyachi Y, et al. Impact of the preoperative bone mineral density on the outcomes after resection of pancreatic cancer. Surg Today. 2020;50(7):757–66.
Article CAS PubMed Google Scholar
Sharma P, Parikh ND, Yu J, Barman P, Derstine BA, Sonnenday CJ, et al. Bone mineral density predicts posttransplant survival among hepatocellular carcinoma liver transplant recipients. Liver Transpl. 2016;22(8):1092–8.
Article PubMed PubMed Central Google Scholar
Yamada D, Eguchi H, Iwagami Y, Mukai Y, Hashimoto Y, Asaoka T, et al. Patients treated with preoperative chemoradiation for pancreatic ductal adenocarcinoma have impaired bone density, a predictor of distant metastasis. Ann Surg Oncol. 2017;24(12):3715–24.
Toshima T, Yoshizumi T, Ikegami T, Harada N, Itoh S, Mano Y, et al. Impact of osteopenia in liver cirrhosis: special reference to standard bone mineral density with age. Anticancer Res. 2018;38(11):6465–71.
Kirk B, Zanker J, Duque G. Osteosarcopenia: epidemiology, diagnosis, and treatment-facts and numbers. J Cachexia Sarcopenia Muscle. 2020;11(3):609–18.
Article PubMed PubMed Central Google Scholar
Yugawa K, Itoh S, Kurihara T, Yoshiya S, Mano Y, Takeishi K, et al. Skeletal muscle mass predicts the prognosis of patients with intrahepatic cholangiocarcinoma. Am J Surg. 2019;218(5):952–8.
Abe K, Furukawa K, Okamoto T, Matsumoto M, Futagawa Y, Haruki K, et al. Impact of osteopenia on surgical and oncological outcomes in patients with pancreatic cancer. Int J Clin Oncol. 2021;26(10):1929–37.
Article CAS PubMed Google Scholar
Toshima T, Yoshizumi T, Kosai-Fujimoto Y, Inokuchi S, Yoshiya S, Takeishi K, et al. Prognostic impact of osteopenia in patients who underwent living donor liver transplantation for hepatocellular carcinoma. World J Surg. 2020;44(1):258–67.
McMillan DC. The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer. Cancer Treat Rev. 2013;39(5):534–40.
Pinato DJ, North BV, Sharma R. A novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: the prognostic nutritional index (PNI). Br J Cancer. 2012;106(8):1439–45.
Article CAS PubMed PubMed Central Google Scholar
Proctor MJ, McMillan DC, Morrison DS, Fletcher CD, Horgan PG, Clarke SJ. A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer. Br J Cancer. 2012;107(4):695–9.
Article CAS PubMed PubMed Central Google Scholar
Zhang H, Xia H, Zhang L, Zhang B, Yue D, Wang C. Clinical significance of preoperative neutrophil-lymphocyte vs platelet-lymphocyte ratio in primary operable patients with non-small cell lung cancer. Am J Surg. 2015;210(3):526–35.
Watanabe J, Saitsu A, Miki A, Kotani K, Sata N. Prognostic value of preoperative low bone mineral density in patients with digestive cancers: a systematic review and meta-analysis. Arch Osteoporos. 2022;17(1):33.
Article PubMed PubMed Central Google Scholar
Takeda T, Sasaki T, Okamoto T, Ishitsuka T, Yamada M, Nakagawa H, et al. Prognostic impact of osteosarcopenia in patients with advanced pancreatic cancer receiving gemcitabine plus nab-paclitaxel. Pancreatology. 2023;23(3):275–82.
Article CAS PubMed Google Scholar
Straub RH, Cutolo M, Pacifici R. Evolutionary medicine and bone loss in chronic inflammatory diseases—a theory of inflammation-related osteopenia. Semin Arthritis Rheum. 2015;45(2):220–8.
Article PubMed PubMed Central Google Scholar
Cain CJ, Rueda R, McLelland B, Collette NM, Loots GG, Manilay JO. Absence of sclerostin adversely affects B-cell survival. J Bone Miner Res. 2012;27(7):1451–61.
Article CAS PubMed Google Scholar
Lu H, Ouyang W, Huang C. Inflammation, a key event in cancer development. Mol Cancer Res. 2006;4(4):221–33.
Hayes JD, Dinkova-Kostova AT, Tew KD. Oxidative stress in cancer. Cancer Cell. 2020;38(2):167–97.
Article CAS PubMed PubMed Central Google Scholar
Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12(5):489–95.
Shimagaki T, Sugimachi K, Mano Y, Onishi E, Iguchi T, Nakashima Y, et al. Cachexia index as a prognostic predictor after resection of pancreatic ductal adenocarcinoma. Ann Gastroenterol Surg. 2023;7(6):977–86.
Article PubMed PubMed Central Google Scholar
Fujiwara N, Nakagawa H, Kudo Y, Tateishi R, Taguri M, Watadani T, et al. Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma. J Hepatol. 2015;63(1):131–40.
Article CAS PubMed Google Scholar
Hu L, Liu R, Zhang L. Advance in bone destruction participated by JAK/STAT in rheumatoid arthritis and therapeutic effect of JAK/STAT inhibitors. Int Immunopharmacol. 2022;111: 109095.
Article CAS PubMed Google Scholar
Zhang L, Sun Y. Muscle-bone crosstalk in chronic obstructive pulmonary disease. Front Endocrinol (Lausanne). 2021;12: 724911.
Comments (0)